SPX4,145.19-6.75 -0.16%
DIA327.97+0.61 0.19%
IXIC12,657.56-63.03 -0.50%

Alnylam Pharmaceuticals: Q2 Earnings Insights

  Alnylam Pharmaceuticals (NASDAQ:ALNY) reported its Q2 earnings results on Thursday, July 28, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga · 07/28/2022 08:16

 

Alnylam Pharmaceuticals (NASDAQ:ALNY) reported its Q2 earnings results on Thursday, July 28, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Alnylam Pharmaceuticals missed estimated earnings by 25.31%, reporting an EPS of $-2.03 versus an estimate of $-1.62.

Revenue was up $4.26 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.35 which was followed by a 6.8% drop in the share price the next day.

Here's a look at Alnylam Pharmaceuticals's past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -1.84 -1.54 -1.57 -1.6
EPS Actual -1.49 -1.69 -1.51 -1.3
Revenue Estimate 243.02M 233.62M 218.69M 193.18M
Revenue Actual 213.26M 258.54M 187.63M 220.55M

To track all earnings releases for Alnylam Pharmaceuticals VISIT THEIR EARNINGS CALENDAR HERE.

This article was generated by Benzinga's automated content engine and reviewed by an editor.